New research published in Molecular Cell suggests reduced nitric oxide signaling may be tied to greater Alzheimer’s pathology, faster memory decline and disrupted gene regulation in the brain.
By yourNEWS Media Newsroom
New research is challenging long-held assumptions about nitric oxide’s role in Alzheimer’s disease, suggesting that reduced activity of the molecule in the brain may be linked to worse disease outcomes rather than protection from damage.
A study published June 4 in Molecular Cell found that lower nitric oxide activity correlated with greater amyloid-beta plaque buildup, faster memory decline and more severe Alzheimer’s-related changes in both mouse models and human brain tissue.
For years, many researchers believed nitric oxide levels were elevated in Alzheimer’s disease and contributed to neural injury. The new findings suggest the relationship may be more complex and that healthy nitric oxide signaling could help protect brain cells by supporting proper communication and protein regulation.
Nitric oxide is a small gas molecule involved in blood vessel function, circulation, inflammation and cellular signaling. In the brain, researchers found that it also helps regulate alternative splicing, a gene-editing process that allows a single gene to produce different protein instructions for cells.
Alternative splicing is one reason the human brain can achieve high complexity despite a limited number of genes. When the process works properly, brain cells can generate the proteins they need for communication, maintenance and repair. When it breaks down, abnormal protein regulation may contribute to neurodegenerative disease.
The study focused on a nitric oxide-related chemical modification known as S-nitrosylation. Researchers identified a protein called PTBP1 as a key splicing regulator affected by the process. PTBP1 is involved in brain function and has been linked to neurodegenerative disease.
When nitric oxide signaling declined, the researchers found that the splicing system appeared to weaken. Both mouse models and human Alzheimer’s brains showed lower levels of a nitric oxide-related modification called SNO-PTBP1. Those lower levels were associated with worse clinical outcomes, more severe Alzheimer’s pathology and abnormal splicing tied to tau proteins involved in neurodegeneration.
The findings may also help connect Alzheimer’s research with broader questions about vascular health. Alzheimer’s has often been studied through the lens of amyloid plaques and tau tangles, but researchers increasingly recognize that blood flow, endothelial function, inflammation and metabolic health can influence cognitive decline before symptoms become obvious.
Nitric oxide sits at the center of several of those systems. It helps blood vessels remain flexible and responsive. When nitric oxide production falls, circulation may become less efficient, inflammation may increase and endothelial function may worsen. Reduced blood flow to the brain can limit oxygen and nutrient delivery, potentially increasing vulnerability to neurodegenerative damage.
Nitric oxide production naturally declines with age. That decline can be worsened by sedentary habits, poor cardiovascular health, insulin resistance, smoking, chronic inflammation and poor sleep. Researchers said the loss of healthy nitric oxide signaling may represent an underexamined risk factor in brain aging.
Lifestyle factors may help support nitric oxide production. Regular aerobic exercise is one of the most consistent ways to stimulate nitric oxide release because increased blood flow during movement prompts blood vessels to produce more of the molecule.
Diet may also play a role. Nitrate-rich foods such as beets, spinach, arugula, lettuce, celery and other leafy greens contain natural nitrates that the body can convert into nitric oxide. That pathway may help explain why vegetable-rich diets have been associated with better cardiovascular and brain health.
The conversion process depends in part on bacteria in the mouth. Some researchers have warned that frequent use of strong antibacterial mouthwash may disrupt oral bacteria involved in nitric oxide production. Poor sleep, smoking, insulin resistance and chronic inflammation may also suppress nitric oxide signaling over time.
The Molecular Cell study does not prove that increasing nitric oxide prevents Alzheimer’s disease. Researchers emphasized that the work is still early and focuses on biological mechanisms rather than direct treatment recommendations.
Still, the findings may reshape how scientists think about nitric oxide in Alzheimer’s research. Instead of viewing the molecule mainly as a contributor to brain damage, researchers are now examining whether the loss of healthy nitric oxide signaling removes a protective layer that helps brain cells regulate proteins, maintain communication and resist neurodegeneration.
The study adds to growing evidence that Alzheimer’s disease is not driven by a single process. Vascular health, metabolism, inflammation, gene regulation and brain-cell communication may all shape risk and progression, making nitric oxide a potentially important area for future research.
Source: Natural News
Original article
Comments